The Effects of Nicotine Chewing Gum in Parkinson's Disease

Description

The objective of this experiment is: To determine if nicotine chewing gum will improve acute episodes of orthostatic hypotension in PD subjects.

Study Start Date

May 2015

Estimated Completion Date

September 2016

Interventions

  • Dietary Supplement: Nicotine gum

Specialties

  • Internal Medicine: Neurology
  • Neurology: Movement Disorders
  • Physician Assistant: Neurology

MeSH Terms

  • Basal Ganglia Diseases
  • Hypotension
  • Movement Disorders
  • Parkinson Disease

Study ID

New York Institute of Technology -- BHS-1118

Status

Unknown

Trial ID

NCT02452125

Study Type

Interventional

Trial Phase

Phase 1

Enrollment Quota

10

Sponsor

New York Institute of Technology

Inclusion Criteria

  • a diagnosis of PD
  • a diastolic BP less than 90 mmHg
  • and/or a systolic BP lower than 100mHg.

Exclusion Criteria

  • current tobacco users in all forms of tobacco
  • severe dysphasia (difficulty swallowing)
  • previous tobacco users who might be at risk for re-addiction.

Gender

Both

Ages

N/A

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
New York Institute of Technology - Old Westbury, New York 37.1 miles Brian Harper MD 516-686-3700 bharper@nyit.edu

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.